Expertise in
9
conditions

Dr. Michael S. Epstein

Gastroenterology
621 Ridgely Ave, Suite 201, 
Annapolis, MD 
Expertise in
9
conditions
621 Ridgely Ave, Suite 201, 
Annapolis, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Epstein is a Gastroenterologist in Annapolis, Maryland. Dr. Epstein is highly rated in 9 conditions, according to our data. His top areas of expertise are Hemorrhoids, Gastroesophageal Reflux Disease (GERD), Diverticular Disease, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in MD
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

621 Ridgely Ave, Suite 201, Annapolis, MD 21401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Enrollment Status: Completed
Publish Date: June 04, 2021
Intervention Type: Diagnostic test, Procedure
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
53
conditions
Dr. Mouen A. Khashab
Gastroenterology | Emergency Medicine
Expertise in
53
conditions
Dr. Mouen A. Khashab
Gastroenterology | Emergency Medicine

Johns Hopkins University

5601 Lloch Raven Blvd, 
Baltimore, MD 
 (25.3 miles away)
443-444-4714
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients

Mouen Khashab is a Gastroenterologist and an Emergency Medicine provider in Baltimore, Maryland. Dr. Khashab is highly rated in 53 conditions, according to our data. His top areas of expertise are Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass. Dr. Khashab is currently accepting new patients.

Expertise in
28
conditions
Dr. Vikesh K. Singh
Gastroenterology
Expertise in
28
conditions
Dr. Vikesh K. Singh
Gastroenterology

Johns Hopkins University

2360 W Joppa Rd, Joppa Concourse, 
Lutherville, MD 
 (30.4 miles away)
410-933-7495
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients

Vikesh Singh is a Gastroenterologist in Lutherville, Maryland. Dr. Singh is highly rated in 28 conditions, according to our data. His top areas of expertise are Hereditary Pancreatitis, Exocrine Pancreatic Insufficiency, Acute Pancreatitis, Pancreatectomy, and Endoscopy. Dr. Singh is currently accepting new patients.

Expertise in
30
conditions
Dr. Zobair M. Younossi
Gastroenterology
Expertise in
30
conditions
Dr. Zobair M. Younossi
Gastroenterology

Inova Fairfax Hospital Center For Liver Diseases

3300 Gallows Rd Medicine, 
Falls Church, VA 
 (37.7 miles away)
703-776-2540
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Zobair Younossi is a Gastroenterologist in Falls Church, Virginia. Dr. Younossi is highly rated in 30 conditions, according to our data. His top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Hepatitis C, Liver Transplant, and Heart Transplant. Dr. Younossi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Epstein's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 68 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile